{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:13:48Z","timestamp":1762125228843,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.plefa.2021.102267","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T22:39:43Z","timestamp":1615675183000},"page":"102267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Comparison of human and rodent cell models to study myocardial lipid-induced insulin resistance"],"prefix":"10.1016","volume":"167","author":[{"given":"Li-yen","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan F.C.","family":"Glatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilvy M.E.","family":"Geraets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Vanherle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur van den","family":"Wijngaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost J.F.P.","family":"Luiken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda","family":"Nabben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2021.102267_bib0001","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/RES.0000000000000097","article-title":"Assessing cardiac metabolism: a scientific statement from the American Heart Association","volume":"118","author":"Taegtmeyer","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.plefa.2021.102267_bib0002","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.plefa.2021.102267_bib0003","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacbts.2016.11.009","article-title":"Metabolic origins of heart failure","volume":"2","author":"Wende","year":"2017","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.plefa.2021.102267_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165579","article-title":"Re-balancing cellular energy substrate metabolism to mend the failing heart","volume":"1866","author":"Glatz","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.plefa.2021.102267_bib0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pharmthera.2017.08.001","article-title":"Cardiac metabolism\u2014a promising therapeutic target for heart failure","volume":"182","author":"Noordali","year":"2018","journal-title":"Pharmacol. Therap."},{"key":"10.1016\/j.plefa.2021.102267_bib0006","first-page":"1","article-title":"Epidemiology of the inherited cardiomyopathies","author":"McKenna","year":"2020","journal-title":"Nature Rev. Cardiol."},{"key":"10.1016\/j.plefa.2021.102267_bib0007","first-page":"1","article-title":"Advantages and perils of clinical whole-exome and whole-genome sequencing in cardiomyopathy","author":"Mazzarotto","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.plefa.2021.102267_bib0008","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1242\/dmm.030320","article-title":"Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies","volume":"10","author":"Brand\u00e3o","year":"2017","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.plefa.2021.102267_bib0009","first-page":"1","article-title":"Human induced pluripotent stem cells as a disease model system for heart failure","author":"Deicher","year":"2020","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.plefa.2021.102267_bib0010","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.cardfail.2015.04.010","article-title":"Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies","volume":"21","author":"Kamdar","year":"2015","journal-title":"J. Cardiac. Fail."},{"key":"10.1016\/j.plefa.2021.102267_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15420\/ecr.2019.03","article-title":"Applications for induced pluripotent stem cells in disease modelling and drug development for heart diseases","volume":"15","author":"Nakao","year":"2020","journal-title":"Eur. Cardiol. Rev."},{"key":"10.1016\/j.plefa.2021.102267_bib0012","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2009.07.001","article-title":"Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery","volume":"30","author":"Braam","year":"2009","journal-title":"Trends Pharacol. Sci."},{"key":"10.1016\/j.plefa.2021.102267_bib0013","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00424-018-2214-0","article-title":"Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes\u2014a systematic review","volume":"471","author":"Eschenhagen","year":"2019","journal-title":"Eur. J. Physiol."},{"key":"10.1016\/j.plefa.2021.102267_bib0014","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/cvr\/cvn093","article-title":"Insulin signalling in the heart","volume":"79","author":"Bertrand","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.plefa.2021.102267_bib0015","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1194\/jlr.R082933","article-title":"Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization","volume":"59","author":"Glatz","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plefa.2021.102267_bib0016","doi-asserted-by":"crossref","first-page":"14501","DOI":"10.1074\/jbc.275.19.14501","article-title":"Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase","volume":"275","author":"Bonen","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2021.102267_bib0017","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2337\/diabetes.52.7.1627","article-title":"Contraction-induced fatty acid translocase\/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling","volume":"52","author":"Luiken","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2021.102267_bib0018","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.2337\/diabetes.51.10.3113","article-title":"Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT\/CD36","volume":"51","author":"Luiken","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2021.102267_bib0019","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physrev.00003.2009","article-title":"Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease","volume":"90","author":"Glatz","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.plefa.2021.102267_bib0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"Boudina","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.plefa.2021.102267_bib0021","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.2337\/db16-0727","article-title":"Palmitate-induced vacuolar-type H+-ATPase inhibition feeds forward into insulin resistance and contractile dysfunction","volume":"66","author":"Liu","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2021.102267_bib0022","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1172\/JCI10583","article-title":"Cellular mechanisms of insulin resistance","volume":"106","author":"Shulman","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2021.102267_bib0023","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00125-007-0735-8","article-title":"Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification","volume":"50","author":"Ouwens","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.plefa.2021.102267_bib0024","doi-asserted-by":"crossref","first-page":"H823","DOI":"10.1152\/ajpheart.00986.2003","article-title":"Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function","volume":"286","author":"White","year":"2004","journal-title":"Am. J. Physiol. Heart Circ Physiol."},{"key":"10.1016\/j.plefa.2021.102267_bib0025","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/0024-3205(91)90310-8","article-title":"Highly insulin-responsive isolated rat heart muscle cells yielded by a modified isolation method","volume":"49","author":"Fischer","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.plefa.2021.102267_bib0026","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1634\/stemcells.2004-0184","article-title":"Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures","volume":"23","author":"Passier","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.plefa.2021.102267_bib0027","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.227512","article-title":"Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview","volume":"111","author":"Mummery","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.plefa.2021.102267_bib0028","doi-asserted-by":"crossref","first-page":"C1549","DOI":"10.1152\/ajpcell.00334.2009","article-title":"Differential regulation of cardiac glucose and fatty acid uptake by endosomal pH and actin filaments","volume":"298","author":"Steinbusch","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.plefa.2021.102267_bib0029","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0022-2275(20)37241-2","article-title":"Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: involvement of sarcolemmal proteins","volume":"38","author":"Luiken","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plefa.2021.102267_bib0030","series-title":"AMPK","first-page":"343","article-title":"Assessment of AMPK-stimulated cellular long-chain fatty acid and glucose uptake","author":"Luiken","year":"2018"},{"key":"10.1016\/j.plefa.2021.102267_bib0031","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.bbadis.2017.12.025","article-title":"Human embryonic stem cell-derived cardiomyocytes as an in vitro model to study cardiac insulin resistance","volume":"1864","author":"Geraets","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.plefa.2021.102267_bib0032","doi-asserted-by":"crossref","first-page":"37530","DOI":"10.1074\/jbc.M112.363630","article-title":"Overexpression of vesicle-associated membrane protein (VAMP) 3, but not VAMP2, protects glucose transporter (GLUT) 4 protein translocation in an in vitro model of cardiac insulin resistance","volume":"287","author":"Schwenk","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2021.102267_bib0033","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/BJ20120060","article-title":"CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes","volume":"448","author":"Angin","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.plefa.2021.102267_bib0034","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/cvr\/cvz060","article-title":"Pivotal role of membrane substrate transporters on the metabolic alterations in the pressure-overloaded heart","volume":"115","author":"Geraets","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.plefa.2021.102267_bib0035","doi-asserted-by":"crossref","first-page":"40567","DOI":"10.1074\/jbc.M100052200","article-title":"Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats","volume":"276","author":"Luiken","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2021.102267_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-19478-9","article-title":"Assessing fatty acid oxidation flux in rodent cardiomyocyte models","volume":"8","author":"Rech","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.plefa.2021.102267_bib0037","doi-asserted-by":"crossref","DOI":"10.1007\/s00424-020-02486-y","article-title":"Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine","author":"Pan","year":"2021","journal-title":"Eur. J. Physiol."},{"key":"10.1016\/j.plefa.2021.102267_bib0038","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.stemcr.2018.11.011","article-title":"Perspectives on the use of human induced pluripotent stem cell-derived cardiomyocytes in biomedical research","volume":"11","author":"Mummery","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.plefa.2021.102267_bib0039","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fphys.2012.00346","article-title":"Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias","volume":"3","author":"Hoekstra","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.plefa.2021.102267_bib0040","series-title":"Genetic Causes of Cardiac Disease","first-page":"341","article-title":"Human induced pluripotent stem cells as platform for functional examination of cardiovascular genetics in a dish","author":"Dirschinger","year":"2019"},{"key":"10.1016\/j.plefa.2021.102267_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165881","article-title":"Metabolic environment in vivo as a blueprint for differentiation and maturation of human stem cell-derived cardiomyocytes","author":"Slaats","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.plefa.2021.102267_bib0042","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3390\/ijms21041520","article-title":"Augmenting vacuolar H+-ATPase function prevents cardiomyocytes from lipid-overload induced dysfunction","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327821000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327821000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:09:50Z","timestamp":1760602190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327821000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":42,"alternative-id":["S0952327821000302"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2021.102267","relation":{},"ISSN":["0952-3278"],"issn-type":[{"type":"print","value":"0952-3278"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of human and rodent cell models to study myocardial lipid-induced insulin resistance","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2021.102267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102267"}}